how-to
Is Spravato Covered by Insurance in 2026?
Table of Contents
- How Spravato Gets Covered: Medical vs. Pharmacy Benefit
- Medicare Coverage for Esketamine in 2026
- Spravato Prior Authorization Requirements and Clinical Criteria
- Spravato Copay Assistance Program 2026: What Help Exists
- What to Do When a Claim Is Denied: Appeals and Medicaid Variance
- Step 1: Read the Denial Letter Carefully
- Step 2: Distinguish Internal vs. External Appeals
- Step 3: Build the Clinical Record
- Step 4: File, Track, and Follow Up
- Medicaid Coverage Varies Significantly by State
- How to Check Your State's Medicaid Coverage
- Mental Health Parity Protections
- Documentation Checklist for Your Appeal
- How to Verify Your Coverage Before Your First Session
- Conclusion
- Frequently Asked Questions
Last Updated: September 21, 2026
How Spravato Gets Covered: Medical vs. Pharmacy Benefit
Is Spravato covered by insurance in 2026? For many patients, yes. But the answer depends on which benefit your plan uses to pay for it, and that single detail changes your out-of-pocket cost more than almost anything else.
Why the Benefit Type Changes Your Out-of-Pocket Cost
A medical benefit typically means you pay a percentage of the cost until you hit your deductible, then a smaller share; a pharmacy benefit usually means a fixed copay per fill.
Medicare Coverage for Esketamine in 2026
Medicare coverage for esketamine generally falls under Medicare Part B when a provider gives the drug and monitors you in a clinical setting, since Part B covers outpatient treatment and Spravato requires supervised administration.
Here is what that means in practice:
- Part B usually covers the drug and the monitoring as a medical service
- You pay your Part B deductible first, then coinsurance on covered amounts
- Some Medicare Advantage plans may handle it differently, so check your specific plan
Spravato Prior Authorization Requirements and Clinical Criteria
Spravato prior authorization requirements are strict, and most insurers want proof that other treatments have not worked. A prior authorization is your plan's approval before treatment starts; without it, a claim can be denied even when treatment is medically appropriate.
Common clinical criteria insurers look for:
- A diagnosis of treatment-resistant depression
- Failure of at least two antidepressant trials at adequate dose and duration
- A confirmed diagnosis from a licensed healthcare provider
- Enrollment in a monitored care setting, sometimes with a risk evaluation program
Treatment-Resistant Depression Diagnosis Criteria
Treatment-resistant depression is generally defined as depression that has not improved after at least two adequate trials of different antidepressants. Your provider documents this history; medication names, doses, and dates of past trials strengthen the case and make medical necessity easier to prove.
Spravato Copay Assistance Program 2026: What Help Exists
Spravato copay assistance program 2026 options can meaningfully lower what you owe, but the biggest mistake is assuming one program covers everything. Help is split across three buckets, the drug, the in-office administration/monitoring fee, and your plan's deductible/coinsurance share, each with its own rules.
The Three Buckets of Spravato Cost
- The drug itself (the esketamine nasal spray units)
- The administration and monitoring service (the required observation period in a certified clinical setting)
- Your plan's cost-sharing (deductible, coinsurance, or copay applied to either of the above)
A copay card or patient assistance program may cover one bucket and not the others. That is why two patients with the same insurance can report very different net costs.
Manufacturer Copay Support
The manufacturer of Spravato operates a copay savings program for commercially insured patients. Key features:
- Eligibility is limited to commercial insurance. Patients on Medicare, Medicaid, TRICARE, VA, or other federal/state health programs are generally excluded due to federal anti-kickback rules.
- Income is not the primary gate, having commercial insurance is. Foundation grants, by contrast, are income-tested.
- Annual caps apply. Most cards cap total assistance per calendar year, so patients on long maintenance schedules should track usage.
- Enrollment is usually done at the certified treatment center, not by the patient alone. Ask your site whether they are enrolled.
Spravato manufacturer copay program and eligibility terms
Foundation and Nonprofit Assistance
When a patient is on Medicare, Medicaid, or uninsured, manufacturer copay cards are off the table. The fallback is independent nonprofit foundations that provide grants for specific disease areas, including treatment-resistant depression.
What to know about foundation grants:
- They are income-tested, usually against a percentage of the federal poverty level.
- They open and close. Funds are replenished periodically, so get on waitlists.
- They usually pay the patient's cost-sharing, not the full drug price, so they work best alongside insurance.
- Diagnosis documentation is required, your provider submits clinical records confirming treatment-resistant depression.
State and Provider-Level Help
Additional levers patients often overlook:
- State pharmaceutical assistance programs. Some states run their own drug assistance programs for residents; eligibility and covered drugs vary widely.
- Certified treatment center financial counselors. Many Spravato sites employ or contract with financial navigators who know which programs are currently open and will handle enrollment paperwork.
- Hospital charity care. If your Spravato is administered through a hospital outpatient department, the hospital's financial assistance policy may reduce or waive your share based on income.
A Practical Order of Operations
- Confirm whether you have commercial insurance or a government program, this determines whether the manufacturer copay card is an option.
- If commercial, ask your treatment site to enroll you in the manufacturer copay program before your first billing cycle.
- If on Medicare/Medicaid/uninsured, ask your provider's financial counselor to screen you for open foundation grants.
- Ask the hospital or clinic whether a charity care application applies.
- Re-check every 3-6 months, since funds and program terms change.
For current eligibility thresholds, annual caps, and open/closed status, always check the official program source directly, since these change throughout the year.
What to Do When a Claim Is Denied: Appeals and Medicaid Variance
A denied claim is not the end of the road, many Spravato denials are overturned on appeal when the right clinical documentation is submitted. Below are the appeal mechanics most articles skip, plus the Medicaid variability that makes coverage differ by state.
Step 1: Read the Denial Letter Carefully
Every denial letter must state:
- The specific reason for denial (e.g., "does not meet medical necessity criteria," "prior authorization not obtained," "experimental/investigational")
- The appeal deadline, commonly 180 days for internal appeals on commercial plans, but this varies
- The appeal address or portal where you must file
- Whether an expedited appeal is available if your condition is urgent
Photograph or scan the letter. You will reference it repeatedly.
Step 2: Distinguish Internal vs. External Appeals
- Internal appeal, a review by your insurer using different reviewers than the original decision; this is your first level.
- External appeal, an independent review organization (IRO) outside your insurer. You generally must exhaust the internal appeal first, unless your plan or state law allows simultaneous review.
- Expedited appeal, available when a delay would seriously jeopardize your health; insurers must generally decide within 72 hours.
Step 3: Build the Clinical Record
Most Spravato denials hinge on documentation, not on whether treatment is appropriate. Ask your provider to submit:
- A letter of medical necessity mapping your history to the plan's criteria
- Medication trial history, names, doses, dates, and duration of at least two prior antidepressants
- Current diagnosis with ICD-10 code for treatment-resistant depression
- PHQ-9 or MADRS scores showing severity and prior treatment response
- Treatment plan describing the monitored clinical setting and observation protocol
- Any prior authorization reference number if one was issued
Step 4: File, Track, and Follow Up
- Submit the appeal in writing (portal or certified mail) before the deadline.
- Keep a log: date sent, method, confirmation number, and representative names.
- Call to confirm receipt within 5 business days.
- Note the decision deadline, typically 30 days for standard internal appeals, 72 hours for expedited.
- If denied again, request external review instructions in writing.
Medicaid Coverage Varies Significantly by State
Unlike Medicare, which has a single national framework under Part B, Medicaid is administered state by state, so Spravato coverage can range from routine to restricted to unavailable depending on where you live.
What varies by state:
- Whether Spravato is on the preferred drug list or requires a state-specific prior authorization
- Which clinical criteria the state applies (some mirror the FDA label; others add stricter step-therapy requirements)
- Whether the drug is carved into managed care or handled through fee-for-service
- Whether the state has a behavioral health carve-out that pays for the treatment separately
- Copay rules, many states charge no copay for mental health services, others charge a small one
How to Check Your State's Medicaid Coverage
- Search your state Medicaid agency's website for the preferred drug list or pharmacy prior authorization documents.
- Call the member services number on your Medicaid card and ask: "Is esketamine nasal spray (Spravato) covered, and what prior authorization criteria apply?"
- Ask whether your plan is managed care or fee-for-service, since that changes who you appeal to.
- If denied, your state Medicaid agency, not just your managed care plan, has a fair hearing process you can request.
State Medicaid agency directory and fair hearing information
Mental Health Parity Protections
The federal Mental Health Parity and Addiction Equity Act requires most plans to cover mental health benefits comparably to medical/surgical benefits (Mental Health and Substance Use Disorder Parity). If your plan imposes stricter limits for depression than for a physical condition, that may be a parity violation, raise it in your appeal and, if unresolved, file a complaint with the relevant federal or state regulator.
Documentation Checklist for Your Appeal
- Copy of the denial letter with reason and deadline
- Letter of medical necessity from your prescriber
- Full antidepressant trial history (names, doses, dates)
- Current diagnosis and ICD-10 code
- Recent PHQ-9 or MADRS scores
- Treatment plan and monitoring protocol
- Prior authorization number (if any)
- Appeal submission confirmation
- Log of all calls with dates and representative names
How to Verify Your Coverage Before Your First Session
Insurance verification before treatment prevents billing surprises. A few calls now can save you a large bill later.

Use this checklist:
- Call your plan and ask if Spravato is a medical or pharmacy benefit
- Confirm whether prior authorization is required
- Ask about your deductible, coinsurance, and any copay
- Check if your provider is in-network or out-of-network
- Ask about copay assistance and patient assistance program options
- Request the answer in writing when possible
| Step | What to Ask | Why It Matters |
|---|---|---|
| Benefit type | Medical or pharmacy? | Sets your cost rules |
| Approval | Is prior authorization needed? | Prevents denials |
| Network | In-network or out-of-network? | Changes your share |
| Assistance | Any copay help? | Lowers out-of-pocket cost |
| Records | What documents are required? | Speeds up approval |
Conclusion
Coverage for Spravato is rarely automatic, and the paperwork can feel overwhelming when you are already managing depression. Trust and Care Mental Health Inc offers specialized treatment for treatment-resistant depression, FDA-approved Spravato esketamine nasal spray, and a monitored clinical setting for safety and support. We also provide treatment-only options for referring providers. Make your appointment today and let our team help you understand your coverage and next steps.
Frequently Asked Questions
What documentation is required for insurance prior authorization for Spravato?
Insurers typically want a confirmed treatment-resistant depression diagnosis, a documented history of at least two failed antidepressants from different classes, a current PHQ-9 or MADRS score, and a signed treatment plan. Some also request the prescriber's REMS certification and the clinic's monitoring protocol. Because plans differ, ask your provider's billing team for the exact checklist your insurer uses before they submit, so nothing bounces back for a missing form.
Is Spravato covered by Medicare and Medicaid in 2026?
Original Medicare generally covers Spravato under Part B when a certified provider administers it and monitors you for at least two hours, since the drug and observation are treated as a single medical service. Medicaid is different: each state sets its own formulary and prior authorization rules, so coverage in Connecticut can differ from a neighboring state. Confirm your specific plan's requirements before scheduling.
How can patients access Spravato financial assistance programs?
Start by asking your clinic whether they participate in the manufacturer's copay assistance program, which can reduce out-of-pocket costs for commercially insured patients. If you are uninsured or on a government plan, ask about patient assistance and foundation grants instead, since manufacturer copay cards usually exclude Medicare and Medicaid. Your provider's billing team can tell you which programs your situation qualifies for and what paperwork is needed.
What happens if my Spravato claim is denied?
A denial is not the end of the process. Request the denial in writing, including the specific reason and the billing codes used, then file an internal appeal within your plan's deadline. A letter of medical necessity from your psychiatrist, plus your medication history and symptom scores, often reverses a denial. If the internal appeal fails, you can request an external review. Ask your provider's office to help draft the appeal, since they handle these regularly.
This article is for general information only and is not medical or insurance advice. Coverage rules, clinical criteria, and assistance programs change. Confirm your specific benefits with your health plan and talk with a qualified healthcare provider about your treatment options.